Titelia

Holdings of T. Rowe Price Mid-Cap Growth Portfolio

T. ROWE PRICE EQUITY SERIES, INC. · Original filing · Compare with another fund · Report an error

Net assets
429.6M $ including 411.3M $ in equities, 95.8 %
Positions
113 in 9 countries
Top ten
19.7 % of net assets
Filed on
Mar 31, 2026
Portfolio shape

Positions

RankCompanySharesValueWeight
101CRISPR Therapeutics AG 20,016952.2K $0.22 %
102CG oncology Inc 13,968945.4K $0.22 %
103DraftKings Inc 41,248891.8K $0.21 %
104Caris Life Sciences Inc 48,694870.6K $0.20 %
105Unity Software Inc 39,500866.6K $0.20 %
106McGraw Hill Inc 59,046808.9K $0.19 %
107Kymera Therapeutics Inc 9,691807.2K $0.19 %
108Aurora Innovation Inc 182,317751.1K $0.17 %
109Amphenol Corp 5,431686.2K $0.16 %
110Revolution Medicines Inc 6,619643.7K $0.15 %
111QuidelOrtho Corp 35,479582.9K $0.14 %
112Nuvalent Inc 4,093419.3K $0.10 %
113Bullish 11,663416.7K $0.10 %

Download this table: CSV, JSON

Sector breakdown

  • Health care 13.0 %
  • Consumer discretionary 12.9 %
  • Industrials 11.9 %
  • Technology 11.5 %
  • Financials 4.3 %
  • Energy 3.9 %
  • Materials 2.0 %
  • Consumer staples 0.8 %
  • Communication 0.3 %
  • Unattributed 39.4 %

Titelia classification, company by company. The unattributed share stays visible.

Currency breakdown

  • USD 100.0 %

The quoted currency of each line, as declared.

Country breakdown

  • United States 92.9 %
  • Bermuda 2.0 %
  • United Kingdom 1.8 %
  • Canada 0.8 %
  • Jersey 0.7 %
  • Switzerland 0.7 %
  • Netherlands 0.6 %
  • Germany 0.4 %
  • Cayman Islands 0.1 %

Shares computed on the equity sleeve.

RankCountryLinesValueShare
1United States104382.1M $92.90 %
2Bermuda18.3M $2.03 %
3United Kingdom17.3M $1.76 %
4Canada13.1M $0.76 %
5Jersey13M $0.73 %
6Switzerland22.8M $0.69 %
7Netherlands12.5M $0.61 %
8Germany11.7M $0.41 %
9Cayman Islands1416.7K $0.10 %
Cite this page

Titelia. "Holdings of T. Rowe Price Mid-Cap Growth Portfolio". https://titelia.com/en/funds/S000002080